Print-ready dossier — use your browser's print dialog to save as PDF.
ACCU-CHEK GUIDE
Model 10436271001 · Roche Diagnostics Operations, Inc. · DI 00365702703209
NBW — System, Test, Blood Glucose, Over The Counter · Class II · 21 CFR 862.1345
UDILibrary device dossier · generated 2026-09-15 · sources: FDA GUDID, openFDA (recalls, MAUDE, 510(k)/PMA), FDA Data Dashboard (inspections, compliance actions), 510(k) summary documents.
Recall history (2)
Initiated
Recall #
Class
Status
Reason
Link basis
2024-05-13
Z-2174-2024
Class II
Open, Classified
The reason for recall is the meters may show an incorrect measurement unit (mmol/L rather than mg/dL) and may result in the wrong unit of measure. Which may subsequently cause an error in interpreting a result as approximately 18 times lower that the actual blood glucose. Potential immediate health consequences of the glucose meter providing a reading in the wrong units of measurement (UOM) may result in inappropriate rescue therapy for presumed hypoglycemia including urgent and repeat administration of carbohydrates. This in turn could lead to frequent episodes of hyperglycemia which is unrecognized and undertreated.Long range consequences of continued use of the affected meters could include mismanagement of the patient s diabetes for longer periods of time potentially resulting in a major health event (in general persistent and/or severe hyperglycemia) that may lead them to seek medical attention, and depending on the duration of hyperglycemia, could contribute to the development of microvascular (i.e., retinopathy, neuropathy, nephropathy) and/or macrovascular (i.e., myocardial infarction, ischemic stroke) complications of diabetes and could lead to fetal damage (abnormal fetal growth and altered organ development and maturation, fetal hypoxemia, spontaneous abortion, and congenital anomalies) in pregnant women. This issue was identified by three initial consumer complaints, with reports that the meters were presenting the incorrect unit of measure.
k number procode
2019-09-30
Z-0747-2020
Class II
Terminated
Potential power issues with the Accu-Chek Guide Blood Glucose Monitoring System.
k number procode
Adverse-event reports — MAUDE (0)
Caveat (required reading): MAUDE report counts cannot be used to compute incidence rates or compare device safety. Reporting is incomplete, duplicated, and spikes with publicity; there is no denominator of devices in use. The peer line is a reporting baseline (average device in the same product code), not a risk measure.
Monthly adverse-event reports for this device versus the product-code average.
Month
This device (reports)
Product-code average (reports per device)
2019-01
0
14.01
2019-02
0
19.34
2019-03
0
21.77
2019-04
0
28.26
2019-05
0
26.14
2019-06
0
24.19
2019-07
0
24.82
2019-08
0
22.58
2019-09
0
20.42
2019-10
0
22.67
2019-11
0
16.37
2019-12
0
19.89
2020-01
0
22.19
2020-02
0
18.44
2020-03
0
20.57
2020-04
0
17.63
2020-05
0
24.77
2020-06
0
30.27
2020-07
0
18.51
2020-08
0
12.33
2020-09
0
19.58
2020-10
0
12.45
2020-11
0
18.13
2020-12
0
18.98
2021-01
0
16.35
2021-02
0
17.07
2021-03
0
18.21
2021-04
0
19.62
2021-05
0
20
2021-06
0
19.7
2021-07
0
28.06
2021-08
0
17.13
2021-09
0
21.17
2021-10
0
19.14
2021-11
0
16.63
2021-12
0
23.6
2022-01
0
16.23
2022-02
0
15.33
2022-03
0
17.98
2022-04
0
16.62
2022-05
0
18.6
2022-06
0
14.8
2022-07
0
14.55
2022-08
0
8
2022-09
0
9.32
2022-10
0
8.08
2022-11
0
11.65
2022-12
0
7.24
2023-01
0
13.11
2023-02
0
9.6
2023-03
0
9.9
2023-04
0
7.78
2023-05
0
36.62
2023-06
0
23.03
2023-07
0
13.17
2023-08
0
11.24
2023-09
0
6.48
2023-10
0
6.48
2023-11
0
4.73
2023-12
0
4.39
2024-01
0
8.58
2024-02
0
2.73
2024-03
0
7.97
2024-04
0
4.02
2024-05
0
7.3
2024-06
0
5.13
2024-07
0
3.64
2024-08
0
3.3
2024-09
0
3.83
2024-10
0
4.44
2024-11
0
2.81
2024-12
0
5.57
2025-01
0
5.49
2025-02
0
2.66
2025-03
0
2.86
2025-04
0
3.69
2025-05
0
4.88
2025-06
0
3.09
2025-07
0
3.13
2025-08
0
4.73
2025-09
0
2.75
2025-10
0
3.59
2025-11
0
3.6
2025-12
0
2.64
2026-01
0
4.2
2026-02
0
2.35
2026-03
0
3.51
2026-04
0
3.03
2026-05
0
3.02
2026-06
0
4.17
This device (reports/month)Average device in NBW (reports/device/month)
Regulatory clearances
K160944 SESE 2016-08-31 (k number procode)
Predicate lineage
K160944 — cited as predicate by K203711, K213131
Lineage extracted from public 510(k) summary text (heuristic).
Manufacturer compliance record — Roche Diagnostics Operations, Inc.
NAI 2023-11-30 Roche Molecular Systems, Inc. · 0 citations
NAI 2022-12-07 Roche Diagnostics Operations, Inc. · 0 citations
NAI 2022-09-23 Ventana Medical Systems, Inc. · 0 citations
NAI 2022-09-15 Ventana Medical Systems, Inc. · 0 citations
NAI 2021-07-29 Ventana Medical Systems, Inc. · 0 citations
NAI 2020-02-26 Ventana Medical Systems, Inc. · 0 citations
VAI 2019-08-29 Roche Diagnostics GmbH · 0 citations
NAI 2019-08-14 Ventana Medical Systems, Inc. · 0 citations
VAI 2019-07-25 Roche Diabetes Care, Inc. · 3 citations
VAI 2019-06-27 Roche Diagnostics Operations, Inc. · 1 citations
NAI 2018-04-19 Roche Diagnostics GmbH · 0 citations
NAI 2018-04-12 Roche Diagnostics GmbH · 0 citations
NAI 2017-07-24 Roche Molecular Systems, Inc. · 0 citations
NAI 2017-07-13 Ventana Medical Systems, Inc. · 0 citations
NAI 2017-02-27 Roche Molecular Systems, Inc. · 0 citations
VAI 2017-02-02 Roche Diabetes Care GmbH · 1 citations
NAI 2016-11-18 Roche Diagnostics GmbH · 0 citations
NAI 2016-10-14 Roche Diagnostics Operations, Inc. · 0 citations
NAI 2016-09-01 Roche Molecular Systems, Inc. · 0 citations
VAI 2016-08-15 Roche Diagnostics Operations, Inc. · 1 citations